ATRX Adhera Therapeutics Inc

Price (delayed)

$0.1

Market cap

$1.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.41

Enterprise value

$7.56M

Highlights
The gross profit has surged by 100% year-on-year
The net income has soared by 72% YoY and by 14% from the previous quarter
The quick ratio has dropped by 100% year-on-year
ATRX's revenue has dropped by 100% year-on-year

Key stats

What are the main financial stats of ATRX
Market
Shares outstanding
11.63M
Market cap
$1.16M
Enterprise value
$7.56M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$1.63M
EBITDA
-$1.63M
Free cash flow
-$240,000
Per share
EPS
-$0.41
Free cash flow per share
-$0.02
Book value per share
-$1.43
Revenue per share
$0
TBVPS
$0
Balance sheet
Total assets
$1,000
Total liabilities
$15.51M
Debt
$6.39M
Equity
-$15.51M
Working capital
-$15.51M
Liquidity
Debt to equity
-0.41
Current ratio
0
Quick ratio
0
Net debt/EBITDA
-3.92
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-8,451.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRX stock price

How has the Adhera Therapeutics stock price performed over time
Intraday
4.06%
1 week
-4.58%
1 month
-16.67%
1 year
96.08%
YTD
140.96%
QTD
-5.66%

Financial performance

How have Adhera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$824,000
Net income
-$3.24M
Gross margin
N/A
Net margin
N/A
ATRX's revenue has dropped by 100% year-on-year
The gross profit has surged by 100% year-on-year
Adhera Therapeutics's operating income has surged by 92% YoY and by 60% QoQ
The net income has soared by 72% YoY and by 14% from the previous quarter

Growth

What is Adhera Therapeutics's growth rate over time

Valuation

What is Adhera Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Adhera Therapeutics's EPS has surged by 65% YoY and by 16% QoQ
ATRX's equity is down by 31% year-on-year and by 5% since the previous quarter
ATRX's revenue has dropped by 100% year-on-year

Efficiency

How efficient is Adhera Therapeutics business performance
The ROA has plunged by 108% from the previous quarter

Dividends

What is ATRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRX.

Financial health

How did Adhera Therapeutics financials performed over time
ATRX's total assets is 100% smaller than its total liabilities
The quick ratio has dropped by 100% year-on-year
ATRX's total assets has dropped by 100% year-on-year
The debt is 141% greater than the equity
ATRX's equity is down by 31% year-on-year and by 5% since the previous quarter
Adhera Therapeutics's debt to equity has increased by 16% YoY and by 4.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.